CANNABIS SCIENCE I COM USD0.001 (CBIS)

0.05
0.00 3.81
OTC
Prev Close 0.05
Open 0.05
Day Low/High 0.05 / 0.05
52 Wk Low/High 0.01 / 0.14
Volume 4.58M
Exchange OTC
Shares Outstanding 2466.80B
Market Cap 128.27M
Div & Yield N.A. (N.A)

Latest News

GWPH Momentum Passed Around to Other Pot Stocks

GWPH Momentum Passed Around to Other Pot Stocks

GW Pharmaceuticals saw its stock price surge amid news of a successful Epidiolex clinical trial. But that high also generated buzz across pot stocks at large.

6 Penny Stocks That Could Be Killing Your Portfolio Right Now

6 Penny Stocks That Could Be Killing Your Portfolio Right Now

Openfolio surveyed the portfolios of its pool of over 20,000 investors to see the effect penny stocks have on overall performance.

Government Pot Contract Open for Bids, but Nobody Wants It

Government Pot Contract Open for Bids, but Nobody Wants It

Researchers complain the pot the government now supplies is of poor quality. The government contract is open for bidding, but growers say the hurdles are insurmountable.

Marijuana Stocks Need to Grow Their Balance Sheets

Marijuana Stocks Need to Grow Their Balance Sheets

Penny stock publisher Peter Leeds finds most pot companies to be very high risk and cautions investors to wait until prices drop.

Beware of Getting High on Marijuana Stocks

Beware of Getting High on Marijuana Stocks

Investing in hot growth stocks at high prices often ends badly.

Medical Marijuana Lights up a Slow Season

Changes in federal law could affect MedBox's markets.

Cannabis Science And World AIDS Institute Announce Appointment Of Dr. Robert Melamede To Scientific Advisory Board

Cannabis Science And World AIDS Institute Announce Appointment Of Dr. Robert Melamede To Scientific Advisory Board

Cannabis Science Inc (NASD OTC: CBIS) and the World AIDS Institute announced today the appointment of Robert Melamede, PhD, Professor of Biology at the University of Colorado, Colorado Springs and CEO of Cannabis...

Cannabis Science Appoints Dr. J. Thomas August Professor, Pharmacology And Molecular Sciences, And Oncology At The Johns Hopkins University School Of Medicine To The CBIS Scientific Advisory Board

Cannabis Science Appoints Dr. J. Thomas August Professor, Pharmacology And Molecular Sciences, And Oncology At The Johns Hopkins University School Of Medicine To The CBIS Scientific Advisory Board

Cannabis Science (CBIS) announced today the appointment of J. Thomas August, MD, Professor, Pharmacology and Molecular Sciences, and Oncology, The Johns Hopkins School of Medicine, to the Company’s Scientific...

Cannabis Science Announces Initiation Of GMP Development Plan For CS-TATI-1

Cannabis Science Announces Initiation Of GMP Development Plan For CS-TATI-1

Cannabis Science ( CBIS), a pioneering U.S.

Cannabis Sciences Reports On Introduction Of H.Res. 6187

Cannabis Sciences Reports On Introduction Of H.Res. 6187

Cannabis Science Inc., (OTC: CBIS).

Cannabis Science Presents At World AIDS Institute Treatment Horizons Satellite Symposium During AIDS 2012 In Washington DC

Cannabis Science Presents At World AIDS Institute Treatment Horizons Satellite Symposium During AIDS 2012 In Washington DC

Cannabis Science Inc. (OTCBB:CBIS) announced today the presentation on the effects of phytocannabinoid inhibition on HIV TAT at the World AIDS Institute Treatment Horizons Satellite Symposium during AIDS 2012 in ...

Dr. Robert Melamede, CEO, Cannabis Science, Presents At World AIDS Institute Legislative Briefing

Dr. Robert Melamede, CEO, Cannabis Science, Presents At World AIDS Institute Legislative Briefing

Cannabis Science Inc., (CBIS) on Friday, July 20th Robert Melamede PhD, CEO of Cannabis Science presented at the Treatment Horizons Briefing at the Rayburn Legislative Office Building in Washington D.

Cannabis Science Announces Mariel Selbovitz, MPH Appointed Vice President Of Research Program Development

Cannabis Science Announces Mariel Selbovitz, MPH Appointed Vice President Of Research Program Development

Cannabis Science Inc (OTCBB: CBIS) announced the appointment of Mariel Selbovitz, MPH as Vice President of Research Program Development, reflecting the maturing direction of the company with the initiation of the...

Strategic Health Resources LLC Retained By Cannabis Science For Government Relations To Identify Opportunities And Collaborative Research

Strategic Health Resources LLC Retained By Cannabis Science For Government Relations To Identify Opportunities And Collaborative Research

Cannabis Science, Inc. (OTCBB: CBIS), a pioneering US biotech company developing pharmaceutical cannabis products, is pleased to announce Strategic Health Resources LLC, an Arlington, VA-based biomedical and health...

Cannabis Science Provides Update On Its “Trimcare Brand” Acquisition

Cannabis Science Provides Update On Its “Trimcare Brand” Acquisition

Cannabis Science, Inc. (CBIS), a pioneering U.

Dr. Roscoe M. Moore Jr., U.S. Assistant Surgeon General (Retired), Appointed To Cannabis Science Scientific Advisory Board

Dr. Roscoe M. Moore Jr., U.S. Assistant Surgeon General (Retired), Appointed To Cannabis Science Scientific Advisory Board

Dr. Robert Melamede, President and CEO of Cannabis Science (CBIS), announced today that Roscoe Moore, DVM, PhD, MPH has been appointed to the Scientific Advisory Board.

Cannabis Science To Present At XIX International AIDS Conference

Cannabis Science To Present At XIX International AIDS Conference

Dr. Robert Melamede, President and CEO of Cannabis Science (CBIS.

Cannabis Science Initiates HIV TAT Anti-Viral Drug Development Program; CS-TATI-1 Lead Hit Discovery Commenced For Pre-Clinical Proof Of Concept Development

Cannabis Science Initiates HIV TAT Anti-Viral Drug Development Program; CS-TATI-1 Lead Hit Discovery Commenced For Pre-Clinical Proof Of Concept Development

Cannabis Science (CBIS.OB) announced today the initiation of a research program to explore the commercial development of Phytocannabinoid-based therapeutics for drug resistant HIV infection.